Xuedong Wang, MD in Pasadena, CA - Medicare Pathology

Xuedong Wang, MD is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Pasadena, California. He graduated from medical school in 1986 and has 38 years of diverse experience with area of expertise as Pathology. He is a member of the group practice The Huntington Medical Foundation and his current practice location is 100 W California Blvd, Pasadena, California. You can reach out to his office (for appointments etc.) via phone at (626) 347-5000.

Xuedong Wang is licensed to practice in California (license number A63196) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1275558298.

Contact Information

	Xuedong Wang, MD
	100 W California Blvd, Pasadena, CA 91105-3010
	(626) 347-5000
	(626) 397-2156

Physician's Profile

Full Name	Xuedong Wang
Gender	Male
Speciality	Pathology
Experience	38 Years
Location	100 W California Blvd, Pasadena, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Xuedong Wang graduated from medical school in 1986

NPI Data:

NPI Number: 1275558298
Provider Enumeration Date: 07/12/2006
Last Update Date: 03/29/2013

Medicare PECOS Information:

PECOS PAC ID: 6507051604
Enrollment ID: I20101115001232

Medical Identifiers

Medical identifiers for Xuedong Wang such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1275558298	NPI	-	NPPES
WA63196A	Medicaid	CA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207ZP0102X	Pathology - Anatomic Pathology & Clinical Pathology	A63196 (California)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Huntington Memorial Hospital	Pasadena, CA	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
The Huntington Medical Foundation	4587631601	72

News Archive

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

MTG Biotherapeutics, an immuno-oncology company developing novel therapeutics for the treatment of cancer, today announced that the US Food and Drug Administration has granted Orphan Drug Designation for MTG-201, an advanced biologic therapy targeting Dickkopf-3 gene defects in various cancers, for the treatment of malignant mesothelioma.

Baxter plans to create two independent global healthcare companies

Baxter International Inc. today announced plans to create two separate, independent global healthcare companies - one focused on developing and marketing innovative biopharmaceuticals and the other on life-saving medical products. Both will be global leaders in their respective markets.

Bipolar disorder patients hold contradictory self-associations

Symptomatic bipolar disorder patients have a marked discrepancy between their automatic and "thought-out" views of themselves, research suggests.

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

Lexicon Pharmaceuticals, Inc. today announced that it has priced its offering of $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes due 2021 (the "Convertible Notes") in a private offering within the United States.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Xuedong Wang allows following entities to bill medicare on his behalf.

Entity Name	The Huntington Medical Foundation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1154467181 PECOS PAC ID: 4587631601 Enrollment ID: O20040923000968

News Archive

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

Baxter plans to create two independent global healthcare companies

Bipolar disorder patients hold contradictory self-associations

Symptomatic bipolar disorder patients have a marked discrepancy between their automatic and "thought-out" views of themselves, research suggests.

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

Entity Name	Huntington Pathology Medical Group Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1265465405 PECOS PAC ID: 6507820719 Enrollment ID: O20130425000028

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

Baxter plans to create two independent global healthcare companies

Bipolar disorder patients hold contradictory self-associations

Symptomatic bipolar disorder patients have a marked discrepancy between their automatic and "thought-out" views of themselves, research suggests.

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Xuedong Wang is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Xuedong Wang, MD 5700 Southwyck Blvd, Toledo, OH 43614-1509 Ph: (800) 288-8325	Xuedong Wang, MD 100 W California Blvd, Pasadena, CA 91105-3010 Ph: (626) 347-5000

News Archive

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

Baxter plans to create two independent global healthcare companies

Bipolar disorder patients hold contradictory self-associations

Symptomatic bipolar disorder patients have a marked discrepancy between their automatic and "thought-out" views of themselves, research suggests.

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

Pathology Doctors in Pasadena, CA

Violeta M Navasardian, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1546 E Washington Blvd, Pasadena, CA 91104 Phone: 626-791-2552 Fax: 626-791-2506
Danielle Lu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 W California Blvd, Pasadena, CA 91105 Phone: 626-397-5000 Fax: 626-397-2156
Dr. Brit S Shackley, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 W California Blvd, Pasadena, CA 91105 Phone: 626-397-8616 Fax: 626-397-2156
Dr. Steve Fu-min Tsai, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 393 E Walnut St, 3rd Floor Phrs, Pasadena, CA 91188 Phone: 626-405-7914
Parakrama T Chandrasoma, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 405 Linda Vista Ave, Pasadena, CA 91105 Phone: 323-226-4600 Fax: 323-226-5927
Sachiv Sheth, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 W California Blvd, Pasadena, CA 91105 Phone: 626-352-1444

Xuedong Wang, MD - Medicare Pathology in Pasadena, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

Baxter plans to create two independent global healthcare companies

Bipolar disorder patients hold contradictory self-associations

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

Medicare Reassignments

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

Baxter plans to create two independent global healthcare companies

Bipolar disorder patients hold contradictory self-associations

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

Baxter plans to create two independent global healthcare companies

Bipolar disorder patients hold contradictory self-associations

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

Baxter plans to create two independent global healthcare companies

Bipolar disorder patients hold contradictory self-associations

Lexicon prices $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes

Pathology Doctors in Pasadena, CA